Neoadjuvant Combination Biotherapy With Ipilimumab and Nivolumab or Nivolumab Alone
Clinical trial NCT02736123 · WITHDRAWN
Trial details
- NCT number
- NCT02736123
- Sponsor
- University of Pittsburgh
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-02-09
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.